Skip to main content
. 2022 Sep 5;14:167. doi: 10.1186/s13102-022-00554-7

Table 2.

Patient assessment data following intervention

Outcome measure T1 mean (SD) Mean 2 (SD) Mean diff. 95.00% CI of diff. Adjust p value Effect size
6-MWT
T1 vs. T2 566.9 (145.2) 602 (143.2) − 35.06 − 84.75 to 14.63 0.237 0.242
T1 vs. T3 646.5 (55.3) − 79.56 − 131.1 to − 28.01 0.004** 0.55
T1 vs. T4 604.3 (124.4) − 37.33 − 111.5 to 36.80 0.628 0.26
T1 vs. T5 615.3 (94.9) − 48.4 − 83.90 to − 12.89 0.009** 0.33
Bruce
T1 vs. T2 32.95 (6.42) 39.99 (7.88) − 7.044 − 11.93 to − 2.159 0.006** 1.10
T1 vs. T3 42.01 (7.85) − 9.058 − 16.44 to − 1.674 0.017* 1.41
STS
T1 vs. T2 15.14 (6.44) 17.76 (6.27) − 2.622 − 5.063 to − 0.181 0.032* 0.41
T1 vs. T3 19.53 (6.93) − 4.387 − 7.402 to − 1.371 0.003** 0.68
T1 vs. T4 17.59 (8.52) − 2.445 − 6.311 to 1.420 0.376 0.38
T1 vs. T5 19.07 (8.03) − 3.924 − 7.607 to − 0.241 0.035* 0.61
HGS-D
T1 vs. T2 29.07 (9.79) 32.82 (8.51) − 0.146 − 0.263 to − 0.029 0.011* 0.38
T1 vs. T3 33.5 (8.69) − 0.162 − 0.283 to − 0.040 0.007** 0.45
T1 vs. T4 31.35 (9.21) − 0.088 − 0.232 to 0.057 0.429 0.23
T1 vs T5 35.09 (9.83) − 0.207 − 0.338 to − 0.076 0.002** 0.62
HGS-N
T1 vs. T2 25.43 (9.91) 30.85 (8.35) − 5.424 − 8.985 to − 1.864 0.002** 0.55
T1 vs. T3 27.81 (8.41) − 2.377 − 5.412 to 0.6578 0.172 0.24
T1 vs. T4 28.35 (8.27) − 2.924 − 6.937 to 1.089 0.228 0.29
T1 vs. T5 31.59 (9.89) − 6.16 − 10.47 to − 1.850 0.004** 0.62
FACT-BMT
T1 vs. T2 116.4 (14.16) 117.7 (17.0) − 1.216 − 7.092 to 4.659  > 0.99 0.09
T1 vs. T3 123.4 (15.12) − 6.922 − 12.36 to − 1.481 0.01* 0.49
T1 vs. T4 121.5 (15.78) − 5.008 − 14.26 to 4.249 0.583 0.36
T1 vs. T5 122.5 (17.83) − 6.018 − 14.30 to 2.266 0.236 0.43
FACT-G
T1 vs. T2 85.98 (10.98) 88.25 (12.52) − 2.268 − 7.011 to 2.474 0.804 0.21
T1 vs. T3 91.23 (11.76) − 5.245 − 9.130 to − 1.360 0.001** 0.48
T1 vs. T4 90.92 (10.91) − 4.932 − 12.20 to 2.334 0.293 0.45
T1 vs. T5 91.02 (12.57) − 5.033 − 11.64 to 1.578 0.195 0.46

*p < 0.05, **p < 0.01